Rhumbline Advisers grew its holdings in Mirion Technologies, Inc. (NYSE:MIR – Free Report) by 91.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 608,834 shares of the company’s stock after acquiring an additional 290,232 shares during the period. Rhumbline Advisers owned about 0.26% of Mirion Technologies worth $14,161,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also modified their holdings of the stock. Invesco Ltd. grew its stake in Mirion Technologies by 713.2% during the 2nd quarter. Invesco Ltd. now owns 2,617,252 shares of the company’s stock worth $56,349,000 after purchasing an additional 2,295,414 shares in the last quarter. Loomis Sayles & Co. L P purchased a new position in shares of Mirion Technologies in the 2nd quarter valued at about $34,269,000. Massachusetts Financial Services Co. MA grew its position in shares of Mirion Technologies by 40.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 5,391,772 shares of the company’s stock worth $125,413,000 after buying an additional 1,558,104 shares in the last quarter. Hood River Capital Management LLC purchased a new stake in shares of Mirion Technologies during the second quarter worth approximately $31,655,000. Finally, Conestoga Capital Advisors LLC acquired a new stake in Mirion Technologies in the third quarter valued at approximately $31,443,000. 78.51% of the stock is currently owned by institutional investors and hedge funds.
Mirion Technologies Stock Performance
Shares of MIR stock opened at $21.49 on Thursday. The stock’s 50-day moving average is $24.48 and its two-hundred day moving average is $23.96. The firm has a market cap of $5.46 billion, a price-to-earnings ratio of 195.42 and a beta of 0.97. Mirion Technologies, Inc. has a 1 year low of $12.00 and a 1 year high of $30.28. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.36 and a current ratio of 2.84.
Wall Street Analysts Forecast Growth
MIR has been the subject of several analyst reports. Morgan Stanley initiated coverage on shares of Mirion Technologies in a report on Friday, January 23rd. They set an “equal weight” rating and a $29.00 price target for the company. Evercore started coverage on shares of Mirion Technologies in a research report on Tuesday, November 25th. They set an “outperform” rating and a $29.00 price objective for the company. Citigroup lowered their target price on shares of Mirion Technologies from $32.00 to $29.00 and set a “buy” rating for the company in a research note on Thursday, February 12th. The Goldman Sachs Group cut their price target on Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, February 12th. Finally, JPMorgan Chase & Co. upped their price objective on Mirion Technologies from $28.00 to $34.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $28.38.
Check Out Our Latest Stock Analysis on MIR
Insider Activity
In other news, Director Lawrence D. Kingsley sold 350,000 shares of Mirion Technologies stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $24.73, for a total value of $8,655,500.00. Following the transaction, the director directly owned 3,509,075 shares of the company’s stock, valued at $86,779,424.75. The trade was a 9.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 6.30% of the company’s stock.
Mirion Technologies Company Profile
Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.
Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.
See Also
- Five stocks we like better than Mirion Technologies
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Want to see what other hedge funds are holding MIR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mirion Technologies, Inc. (NYSE:MIR – Free Report).
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
